Xiang Gao
Vermögen: 864 Mio $ am 31.10.2026
Vermögen: 864 Mio $ am 31.10.2026
Xiang Gao is the founder of GemPharmatech Co., Ltd., established in 2017, holding the title of Chairman since 2017.
Current jobs include Independent Non-Executive Director at Alphamab Oncology starting in 2025 and Independent Non-Executive Director at China Huajun Group Ltd. starting in 2026.
Education history includes a doctorate from Thomas Jefferson University conferred in 1994, a graduate degree from Nanjing University conferred in 1988, and an undergraduate degree from Nanjing University conferred in 1985.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.09.2026 | 196.417.185 ( 47,91 % ) | 864 Mio $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GEMPHARMATECH CO., LTD. | Gründer | 29.12.2017 |
| ALPHAMAB ONCOLOGY | Direktor/Vorstandsmitglied | 30.06.2025 |
| CHINA HUAJUN GROUP LIMITED | Direktor/Vorstandsmitglied | 01.09.2026 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Huajun Group Ltd.
China Huajun Group Ltd. Pulp & PaperProcess Industries Manufactures and prints printing, packaging and paper products | Process Industries |
Nanjing University
Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GemPharmatech Co., Ltd.
GemPharmatech Co., Ltd. BiotechnologyHealth Technology Specializing in the research and development of humanized models and drug screening technologies | Health Technology |
Alphamab Oncology
Alphamab Oncology BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in development manufacturing and commercialization of therapeutics for cancer treatment | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen